Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Pharmaceutical drugs targeting dyslipidemia and cardiovascular disease (CVD) may increase the risk of fatty liver disease and other metabolic disorders. To identify potential novel CVD drug targets without these adverse effects, we perform genome-wide analyses of participants in the HUNT Study in Norway (n = 69,479) to search for protein-altering variants with beneficial impact on quantitative blood traits related to cardiovascular disease, but without detrimental impact on liver function. We identify 76 (11 previously unreported) presumed causal protein-altering variants associated with one or more CVD- or liver-related blood traits. Nine of the variants are predicted to result in loss-of-function of the protein. This includes ZNF529:p.K405X, which is associated with decreased low-density-lipoprotein (LDL) cholesterol (P = 1.3 × 10−8) without being associated with liver enzymes or non-fasting blood glucose. Silencing of ZNF529 in human hepatoma cells results in upregulation of LDL receptor and increased LDL uptake in the cells. This suggests that inhibition of ZNF529 or its gene product should be prioritized as a novel candidate drug target for treating dyslipidemia and associated CVD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Next-generation genotype imputation service and methods
Das, S., Forer, L., Schönherr, S., Sidore, C., Locke, A. E., Kwong, A., Vrieze, S. I., Chew, E. Y., Levy, S., McGue, M., et al. (2016) · Nature Genetics · doi:10.1038/ng.3656 · Cited by 3,808
Self-citationVariance component model to account for sample structure in genome-wide association studies
Kang, H. M., Sul, J. H., Service, S. K., Zaitlen, N. A., Kong, S.-Y., Freimer, N. B., Sabatti, C., & Eskin, E. (2010) · Nature Genetics · doi:10.1038/ng.548 · Cited by 2,817
Self-citationStatins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials
Sattar, N., Preiss, D., Murray, H. M., Welsh, P., Buckley, B. M., de Craen, A. J., Seshasai, S. R. K., McMurray, J. J., Freeman, D. J., Jukema, J. W., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61965-6 · Cited by 2,436
Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program
Taliun, D., Harris, D. N., Kessler, M. D., Carlson, J., Szpiech, Z. A., Torres, R., Taliun, S. A. G., Corvelo, A., Gogarten, S. M., Kang, H. M., et al. (2021) · Nature · doi:10.1038/s41586-021-03205-y · Cited by 2,213
Self-citation2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.010 · Cited by 1,896
Self-citationThe support of human genetic evidence for approved drug indications
Nelson, M. R., Tipney, H., Painter, J. L., Shen, J., Nicoletti, P., Shen, Y., Floratos, A., Sham, P. C., Li, M. J., Wang, J., et al. (2015) · Nature Genetics · doi:10.1038/ng.3314 · Cited by 1,666
C-reactive protein, fibrinogen, and cardiovascular disease prediction
The Emerging Risk Factors Collaboration (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1107477 · Cited by 1,150
Cohort Profile: The HUNT Study, Norway
Krokstad, S., Langhammer, A., Hveem, K., Holmen, T., Midthjell, K., Stene, T., Bratberg, G., Heggland, J., & Holmen, J. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dys095 · Cited by 1,127
Biobank-driven genomic discovery yields new insight into atrial fibrillation biology
Nielsen, J. B., Thorolfsdottir, R. B., Fritsche, L. G., Zhou, W., Skov, M. W., Graham, S. E., Herron, T. J., McCarthy, S., Schmidt, E. M., Sveinbjornsson, G., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0171-3 · Cited by 876
Self-citation
Research works printed but not linked: 40
- Lund, E. G., Menke, J. G. & Sparrow, C. P. Liver X receptor agonists as potential therapeutic agents for dyslipidemia and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 23, 1169–1177 (2003). · DOI · Paper page
- Newman Connie, B. et al. Statin safety and associated adverse events: a scientific statement from the American Heart Association. Arterioscler. Thromb. Vasc. Biol. 39, e38–e81 (2019).
- Zhou, W. et al. Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. Nat. Genet. 50, 1335–1341 (2018). · DOI · Paper page
- Pilia, G. et al. Heritability of cardiovascular and personality traits in 6,148 Sardinians. PLoS Genet. 2, e132 (2006). · DOI · Paper page
- Trecartin, R. F. et al. beta zero thalassemia in Sardinia is caused by a nonsense mutation. J. Clin. Invest. 68, 1012–1017 (1981). · DOI · Paper page
- Green, R. C. et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet. Med. J. Am. Coll. Med. Genet. 15, 565–574 (2013).
- Liu, D. J. et al. Exome-wide association study of plasma lipids in >300,000 individuals. Nat. Genet. 49, 1758–1766 (2017). · DOI · Paper page
- Klarin, D. et al. Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program. Nat. Genet. 50, 1514–1523 (2018). · DOI · Paper page
- Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet Lond. Engl. 344, 1383–1389 (1994). · DOI · Paper page
- Nielson, C. M. et al. Rare coding variants in ALPL are associated with low serum alkaline phosphatase and low bone mineral density. J. Bone Miner. Res. J. Am. Soc. Bone Miner. Res. 27, 93–103 (2012). · DOI
- Chambers, J. C. et al. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat. Genet. 43, 1131–1138 (2011). · DOI · Paper page
- Zhou, W. et al. Scalable generalized linear mixed model for region-based association tests in large biobanks and cohorts. Nat. Genet. 52, 634–639 (2020). · DOI · Paper page
- Denny, J. C. et al. Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat. Biotechnol. 31, 1102–1110 (2013). · DOI · Paper page
- Wu, P. et al. Mapping ICD-10 and ICD-10-CM codes to phecodes: workflow development and initial evaluation. JMIR Med. Inform. 7, e14325 (2019). · DOI · Paper page
- Silverman, E. K. & Sandhaus, R. A. Clinical practice. Alpha1-antitrypsin deficiency. N. Engl. J. Med. 360, 2749–2757 (2009). · DOI · Paper page
- Fähndrich, S. et al. Cardiovascular risk in patients with alpha-1-antitrypsin deficiency. Respir. Res. 18, 171 (2017). · DOI
- Toldo, S. et al. Alpha-1 antitrypsin inhibits caspase-1 and protects from acute myocardial ischemia-reperfusion injury. J. Mol. Cell. Cardiol. 51, 244–251 (2011). · DOI
- Zhang, G. et al. Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation. Blood 122, 443–455 (2013). · DOI · Paper page
- Rust, R. et al. Nogo-A targeted therapy promotes vascular repair and functional recovery following stroke. Proc. Natl Acad. Sci. USA 116, 14270–14279 (2019). · DOI
- Fan, J.-L., Zhang, L. & Bo, X.-H. MiR-126 on mice with coronary artery disease by targeting S1PR2. Eur. Rev. Med. Pharmacol. Sci. 24, 893–904 (2020).
- Nielsen, J. B. et al. Genome-wide study of atrial fibrillation identifies seven risk loci and highlights biological pathways and regulatory elements involved in cardiac development. Am. J. Hum. Genet. 102, 103–115 (2018). · DOI · Paper page
- Voight, B. F. et al. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet 8, e1002793 (2012). · DOI · Paper page
- Parkes, M., Cortes, A., van Heel, D. A. & Brown, M. A. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat. Rev. Genet. 14, 661–673 (2013). · DOI · Paper page
- Sidore, C. et al. Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers. Nat. Genet. 47, 1272–1281 (2015). · DOI · Paper page
- Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinforma. Oxf. Engl. 26, 2190–2191 (2010). · DOI · Paper page
- Sudlow, C. et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015). · DOI · Paper page
- Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010). · DOI · Paper page
- Fan, Y. et al. Endothelial TFEB (Transcription Factor EB) positively regulates postischemic angiogenesis. Circ. Res. 122, 945–957 (2018). · DOI · Paper page
- Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013). · DOI · Paper page
- Li, H. et al. The sequence alignment/map format and SAMtools. Bioinforma. Oxf. Engl. 25, 2078–2079 (2009). · DOI · Paper page
- Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinforma. Oxf. Engl. 26, 841–842 (2010). · DOI · Paper page
- Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinforma. Oxf. Engl. 26, 139–140 (2010). · DOI · Paper page
- Rom, O. et al. Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice. EBioMedicine 41, 62–72 (2019). · DOI
- Villacorta, L. et al. In situ generation, metabolism and immunomodulatory signaling actions of nitro-conjugated linoleic acid in a murine model of inflammation. Redox Biol. 15, 522–531 (2018). · DOI
- Kraehling, J. R. et al. Genome-wide RNAi screen reveals ALK1 mediates LDL uptake and transcytosis in endothelial cells. Nat. Commun. 7, 13516 (2016). · DOI · Paper page
- Xiong, W. et al. Brown adipocyte-specific pparγ (peroxisome proliferator-activated receptor γ) deletion impairs perivascular adipose tissue development and enhances atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 38, 1738–1747 (2018). · DOI
- Collins, D. R. et al. Truncated variants of apolipoprotein B cause hypobetalipoproteinaemia. Nucleic Acids Res. 16, 8361–8375 (1988). · DOI · Paper page
- Chalasani, N., Vuppalanchi, R., Raikwar, N. S. & Deeg, M. A. Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study. J. Clin. Endocrinol. Metab. 91, 2279–2285 (2006). · DOI
- Haghpanah, S., Davani, M., Samadi, B., Ashrafi, A. & Karimi, M. Serum lipid profiles in patients with beta-thalassemia major and intermedia in southern Iran. J. Res. Med. Sci. J. Isfahan Univ. Med. Sci. 15, 150–154 (2010).
- Buonuomo, P. S. et al. Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride. J. Clin. Lipido. 11, 1329–1337.e3 (2017). · DOI
Cited by
The Polygenic and Monogenic Basis of Blood Traits and Diseases
Vuckovic, D., Bao, E. L., Akbari, P., Lareau, C. A., Mousas, A., Jiang, T., Chen, M.-H., Raffield, L. M., Tardaguila, M., Huffman, J. E., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.008 · Cited by 671
Self-citationCohort profile update: The HUNT study, Norway
Åsvold, B. O., Langhammer, A., Rehn, T. A., Kjelvik, G., Grøntvedt, T. V., Sørgjerd, E. P., Fenstad, J. S., Heggland, J., Holmen, O., Stuifbergen, M. C., et al. (2023) · International Journal of Epidemiology · doi:10.1093/ije/dyac095 · Cited by 409
Self-citationVujkovic, M., Ramdas, S., Lorenz, K. M., Guo, X., Darlay, R., Cordell, H. J., He, J., Gindin, Y., Chung, C., Myers, R. P., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01078-z · Cited by 205
Self-citationThe HUNT Study: a population-based cohort for genetic research
Brumpton, B. M., Graham, S., Surakka, I., Skogholt, A. H., Løset, M., Fritsche, L. G., Wolford, B., Zhou, W., Nielsen, J. B., Holmen, O. L., et al. (2021) · doi:10.1101/2021.12.23.21268305 · Cited by 110
Self-citationHomology-directed gene-editing approaches for hematopoietic stem and progenitor cell gene therapy
Azhagiri, M. K. K., Babu, P., Venkatesan, V., & Thangavel, S. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02565-6 · Cited by 35
Metadata
- Authors
- Nielsen, J. B., Rom, O., Surakka, I., Graham, S. E., Zhou, W., Roychowdhury, T., Fritsche, L. G., Gagliano Taliun, S. A., Sidore, C., Liu, Y., Gabrielsen, M. E., Skogholt, A. H., Wolford, B., Overton, W., Zhao, Y., Chen, J., Zhang, H., Hornsby, W. E., Acheampong, A., Grooms, A., Schaefer, A., Zajac, G. J. M., Villacorta, L., Zhang, J., Brumpton, B., Løset, M., Rai, V., Lundegaard, P. R., Olesen, M. S., Taylor, K. D., Palmer, N. D., Chen, Y.-D., Choi, S. H., Lubitz, S. A., Ellinor, P. T., Barnes, K. C., Daya, M., Rafaels, N., Weiss, S. T., Lasky-Su, J., Tracy, R. P., Vasan, R. S., Cupples, L. A., Mathias, R. A., Yanek, L. R., Becker, L. C., Peyser, P. A., Bielak, L. F., Smith, J. A., Aslibekyan, S., Hidalgo, B. A., Arnett, D. K., Irvin, M. R., Wilson, J. G., Musani, S. K., Correa, A., Rich, S. S., Guo, X., Rotter, J. I., Konkle, B. A., Johnsen, J. M., Ashley-Koch, A. E., Telen, M. J., Sheehan, V. A., Blangero, J., Curran, J. E., Peralta, J. M., Montgomery, C., Sheu, W. H.-H., Chung, R.-H., Schwander, K., Nouraie, S. M., Gordeuk, V. R., Zhang, Y., Kooperberg, C., Reiner, A. P., Jackson, R. D., Bleecker, E. R., Meyers, D. A., Li, X., Das, S., Yu, K., LeFaive, J., Smith, A., Blackwell, T., Taliun, D., Zollner, S., Forer, L., Schoenherr, S., Fuchsberger, C., Pandit, A., Zawistowski, M., Kheterpal, S., Brummett, C. M., Natarajan, P., Schlessinger, D., Lee, S., Kang, H. M., Cucca, F., Holmen, O. L., Åsvold, B. O., Boehnke, M., Kathiresan, S., Abecasis, G. R., Chen, Y. E., Willer, C. J., & Hveem, K.
- Venue
- Nature Communications
- Published
- 2020-12-18
- Volume
- 11
- Issue
- 1
- Pages
- 6417-6417
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W3113925949
- Cited by
- 71
- References
- 17
- FWCI
- 8.77
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Funders
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R35-HL135824)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease. https://app.cochat.ai/papers/10.1038/s41467-020-20086-3
- The paper
- Nielsen, J. B., Rom, O., Surakka, I., Graham, S. E., Zhou, W., Roychowdhury, T., Fritsche, L. G., Gagliano Taliun, S. A., Sidore, C., Liu, Y., Gabrielsen, M. E., Skogholt, A. H., Wolford, B., Overton, W., Zhao, Y., Chen, J., Zhang, H., Hornsby, W. E., Acheampong, A., . . . Hveem, K. (2020). Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease. Nature Communications. https://doi.org/10.1038/s41467-020-20086-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.